Sutro Biopharma, Inc.: Form 8-K, filed Jan 5, 2022
Filed with the SEC on Jan 5, 2022 and accepted by EDGAR at Jan 5, 2022, 17:27 ET.
Items reported
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-22-000081. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.